SOME results of a current experiment in an investigation of the role of endocrine environment in tumorigenesis (Stern et al., 1965 (Stern et al., , 1967 Stern and Mickey, 1967) (Blair et al., 1962) suggest that the physiological interaction is largely independent of the induction stimulus.
at age 55 days.
Induction of mammary gland tumors by a single dose of a chemical carcinogen as defined by Huggins et al. (1961) has served as a model for studying effects of hormonal manipulation. Results from several laboratories appear to be consistent with the findings of Huggins et al. (1962) that progesterone enhances mammary gland tumnor induction, estrogen delays, and a progesterone-estrogen combination inhibits the onset of tumors. Most of these findings are based on work with chemically induced tumors. The similar response of irradiation-induced mammary gland tumors to hormone manipulation (Cronkite et al., 1960) and the hormonal requirements of virus-associated preneoplastic mammary nodules (Blair et al., 1962) suggest that the physiological interaction is largely independent of the induction stimulus.
Results of administration of synthetic steroid antifertility compounds to carcinogen-treated rats are not consistent, possibly because the experimental protocols differed in the regimens of steroid and carcinogen administration. Gruenstein et al. (1964) report no effect on incidence of chemically induced mammary gland tumors while McCarthy (1965) reports an increased incidence and Fletcher et al. (1965) refer to acceleration in both development and growth of mammary gland tumors. Although this study of the long-term effects of steroid antifertility agents is still in progress, some interesting results are sufficiently clear to note at present.
There was a delayed onset of carcinogen-induced mammary gland tumors in enovid-treated rats but no reduction in the final tumor incidence. Many of the control animals developed palpable mammary gland tumors before any of the enovid-treated animals did. As the experiment progressed, tumors developed in the enovid-treated rats and by the end of the observation period, one year of age, nearly all of the carcinogen-treated animals had developed mammary gland tumors. However, there was a lower incidence of tumors of malignant potential in the enovid rats as well as a shift in the relative frequency of malignant and benign tumors. weeks (12 rats) for the enovid and control rats respectively in the earlier cohorts (t a 4s51e P <0t001); and 1208 ± 7-5 weeks (12 rats) and 852 w 2k7 (15 rats) for the enovid and control rays an sne onlyr rts (t = 2X00, P = 0b07; rank sum test with tied ranks, Z = 1-98, P = 0-05).
Mammary gland tumors were classified in increasing order of malignant potential as fibroadenoma, duct adenoma, papillary duct adenoma and carcinoma.
In Table   fo Weekly body weight measurements reflect the effects of both the carcinogen and the enovid treatments. The average daily weight gains for the period 55-60 days for the control animals were 2-95 and 1-64 g./day for the non-DMBA and DMBA-treated rats respectively (t = 3-17, P = 0.002); corresponding rates of gain for the enovid rats were 2-15 and 0-82 g./day (t = 3 04, P = 0.003). The course of development reflected by body weight is summarized in Table III . The altered growth pattern of enovid-treated rats, as reflected by body weights, was very clear and was characterized by fitting an empirical growth curve to the group average weights over the age range days. The curve fitted was: w(t) -W lT 1 + (t/T50)a in which w(t) is the mean weight at age t, W is the limiting weight, T50 is the age at which half of the limit is attained, and a is a parameter characteristic of the rate of growth. The fitted curves are quite representative of the data; the root mean square deviations are 1-6 g. and 2-1 g. for the non-DMBA control and enovid groups respectively. The results of fitting the DMBA-treated rats were somewhat less satisfactory in that the growth pattern is disturbed shortly after ingestion of DMBA, and that in the older tumor bearing rats, the pattern of weight increase can be dominated by tumor growth. In the enovid-treated rats the growth pattern of the DMBA rats was similar to that of the non-DMBA animals in that the values of a and T50 were essentially the same, while W was decreased (to 300 g.). In the DMBAtreated control group, the value of a was reduced (to 1.74), which is interpreted mainly as a reflection of tumor growth in the older animals.
It is beyond the scope of this project to consider the possible physiological significance of the altered growth pattern accompanying enovid treatment. It may nonetheless be of interest to adjust the tumor onset times in the enovidtreated rats to the time scale of the control rats. The adjusted time was computed as: t = 3 45(t)0°693 the numerical results for the two parts of the experiment were as follows: In a sense, the adjusted time scale " accounts for " the increased latency. The results are as though the enovid treatment resulted in a slower biological aging.
DISCUSSION
The endocrine environment studied was that resulting from cyclic administration of the antifertility agent Enovid E. The enovid was given in a routine corresponding to that followed in human use. The literature pertaining to effect of hormonal environment on initiation and development of cancer does not provide a clear guide to anticipation of results of experiments such as the one reported here. The finding of Huggins et al. (1962) that a progesterone-estrogen combination (progesterone 4 mg.-estradiol 17,/, 20 ug.) inhibits mammary gland tumor induction in DMBA-treated female rats whereas progesterone by itself increases and estrogen delays tumor development suggests that a somewhat delicate balance may be involved, and the effects may depend critically on the particular compounds used, their dosage and the regimen followed in their administration.
This possible sensitivity was noted by Hertz and Bailar (1966) in discussing the effect of steroid antifertility agents in humans and may account for the apparent disparity in results of some experiments on the effect of antifertility compounds on the induction of mammary gland tumors. For example, McCarthy (1965) found an increased incidence of mammary cancer in Sprague-Dawley rats treated with 0 25 mg. either of enovid or norlestrin daily for 10 days prior to a single feeding of 8 mg. DMBA, while no difference was found using the larger dosage of 1 mg. daily of the antifertility compounds. On the other hand, Weisburger et al., (1968) by Gruenstein et al. (1964) when they treated Wistar rats for one year with 2-5 mg. 3-methyleholanthrene and 3 mg. enovid given 6 days a week, although the data in that report shows a lengthened onset in the enovidtreated animals.
In our experiment, the delay in onset of induced mammary gland tumors in enovid-treated rats may be related to the finding of significant differences between enovid and non-enovid rats in endocrine and target organs. The In previous work, we found a significant drop in the incidence of carcinogeninduced mammary gland tumors in androgen-sterilized rats. In these animals, the hormonal disturbance provides an internal environment in which the induction of mammary carcinoma is inhibited while the development of ovarian granulosa cell tumors is favored (Stern et al., 1967) .
Androgen-sterility results following a single post-natal injection of testosterone (Barraclough, 1961) . The hormonal state in the androgen-sterile rat is one in which ovulation is blocked by impairment of the hypothalamic regulation of pituitary function (Barraclough and Gorski, 1961) . Cyclic release of lutenizing hormone (LH) is blocked and factors controlling the release of prolactin (LTH) are modified. When adult, the animals are sterile, corpora lutea are absent from the ovaries, but there is maturation of graafian follicles. The mammary glands (Stern et al., 1965) show patchy lobuloalveolar development and secretion.
A comparable hormonal state is obtained by administration of steroid antifertility compounds. As in androgen-sterility, the antifertility effect is due to suppression of ovulation by means of a primary action on the hypothalamus. Holmes and Mandl (1962) induced functional sterility in rats using norethinodrel and reported complete absence of or a reduction in the number of corpora lutea. Although ovulation is not consistently blocked, there appears to be suppression of pituitary LH. In women the progestogen-estrogen combinations inhibit the LH peak (World Health Organization, 1965) . Minaguchi and Meites (1967) report that in rats, enovid reduces the prolactin-inhibiting factor (PIF) content of the hypothalamus presumably promoting prolactin secretion by the pituitary. Stimulation of lobulo-alveolar development and secretory activity in mammary glands was reported by Kahn and Baker (1964) .
The similarity of hormonal states of the androgen-sterile rats and enovidtreated rats provides a basis for anticipating similar carcinogenic response to DMBA. In both cases there is inhibition of carcinogen-induced mammary tumors. In the enovid experiment, animals were observed over a period of one year and the inhibition is manifest as increased latency while in the case of the androgensterile experiment, terminated at age 150 days, inhibition is indicated by decreased incidence.
The development of a mammary tumor in one of the 18 enovid: non-DMBA rats, at age 161 days, is potentially a result of considerable interest. This is particularly the case in view of the concern that a possible hyperestrogenic state resulting from prolonged use of steroid antifertility compounds might result in increased mammary cancer (Hertz and Bailar, 1966 ). Although we have not previously observed mammary cancer in control animals under one year of age, this single occurrence is not so exceptional as to support conclusions of substance.
Increased weight of the liver was present at all ages of necropsy in the enovid animals. There is no evidence that in this respect animals adapt to the treatment and the change appears to be cumulative.
The possibility of a relationship of delayed tumor onset with the slower growth of the enovid-treated rats exists, but is no more than suggested here. The decreased growth rate has been noted in all of the experiments using steroid antifertility compounds referenced. Pincus (1966) ascribed the lower body weight to inhibition of production or release of growth hormone. In either case, there is evidence of action of the compounds at the level of the central nervous system. We have come to regard such action, particularly in the hypothalamus, as relevant to cancer induction and development (Stern and Mickey, 1967; Stern, Mickey and Gorski, 1969) . SUMMARY A steroid antifertility combination was administered cyclically to female rats in order to simulate the intermittent schedule of oral contraception used by women.
There were alterations in endocrine and target organs which were more evident after the equivalent of 10 cycles of treatment than after 30 or 60 estrus cycles. The enovid rats also experienced an altered growth pattern.
Following a single dose of the carcinogen DMBA there was a latency in development, and modified carcinogenic potential, of induced mammary tumors. The latency was accounted for by the slower rate of growth of the enovid animals.
The modified carcinogenic response may be related to the early alteration in internal hormonal environment associated with the enovid treatment.
